G. Northoff et al., Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia, SCHIZOPHR R, 44(3), 2000, pp. 193-211
Catatonia is a psychomotor syndrome with an inability to execute and termin
ate movements completely, leading consecutively to akinesia and posturing,
which both respond almost immediately to benzodiazepines, i.e. gaba-potenti
ators like lorazepam. However, pathophysiological mechanisms of cortical mo
tor and gaba-ergic dysfunction remain unclear. We therefore investigated mo
vement-related cortical potentials (MRPs) and movement kinematics during a
motor task before and after lorazepam.
Ten akinetic catatonic patients were compared with 10 psychiatric (similar
age, sex, medication, and underlying psychiatric disease but without catato
nic syndrome) and 20 healthy controls. MRPs from frontal (F), central(C), a
nd parietal (P) sites were recorded to obtain measures of early and late re
adiness potential and movement potential. Kinematic measures included param
eters for amplitude of movements, peak velocity, average duration of moveme
nts, elevation angle, and angle velocity. The motor task consisted in self-
initiated extension of the right index finger. All catatonic and psychiatri
c control patients received intravenous lorazepam (1 mg), whereas healthy c
ontrols were subjected to a placebo-controlled (10 received lorazepam, 10 r
eceived placebo) double-blind study design.
Catatonics showed a significantly delayed onset of late readiness and movem
ent potential in central electrodes (Cz, C3) compared with psychiatric and
healthy controls. This delayed onset correlated significantly with catatoni
c motor symptoms and movement duration. Lorazepam led to significantly stro
nger delays in onset of late readiness potential in left fronto-parietal (F
3, C3, P3) electrodes in catatonic patients than in psychiatric and healthy
controls.
It is concluded that delayed latencies in late MRP components in catatonic
patients may reflect their inability to execute and terminate movements com
pletely. Differential and stronger response to lorazepam in catatonia sugge
sts dysfunction in inhibitory control of cortical motor function with incre
ased gaba-ergic sensitivity. (C) 2000 Elsevier Science B.V. All rights rese
rved.